AUPH Logo

Aurinia Pharmaceuticals Inc. (AUPH) 

NASDAQ
Market Cap
$1.27B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
562 of 968
Rank in Industry
308 of 556

Largest Insider Buys in Sector

AUPH Stock Price History Chart

AUPH Stock Performance

About Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Insider Activity of Aurinia Pharmaceuticals Inc.

Over the last 12 months, insiders at Aurinia Pharmaceuticals Inc. have bought $0 and sold $2.11M worth of Aurinia Pharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at Aurinia Pharmaceuticals Inc. have bought $424,299 and sold $15.8M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $178,284 was made by MILNE GEORGE M JR (director) on 2023‑03‑02.

List of Insider Buy and Sell Transactions, Aurinia Pharmaceuticals Inc.

2024-11-11Saledirector
4,557
0.0032%
$8.43$38,416+2.59%
2024-11-11Saledirector
5,241
0.0036%
$8.43$44,182+2.59%
2024-08-06SaleChief Commercial Officer
18,249
0.0121%
$5.31$96,902+26.69%
2024-05-21Saledirector
4,946
0.0036%
$5.74$28,390+20.54%
2024-05-21Saledirector
5,252
0.0038%
$5.74$30,146+20.54%
2024-05-21Saledirector
5,630
0.004%
$5.74$32,316+20.54%
2024-05-21Saledirector
520
0.0004%
$5.74$2,985+20.54%
2024-05-21Saledirector
5,610
0.004%
$5.74$32,201+20.54%
2024-03-06SaleChief Executive Officer
126,981
0.0894%
$5.60$711,094+0.45%
2024-03-06SaleEVP, Ops & Strategy
40,665
0.0282%
$5.51$224,064+0.45%
2024-03-06SaleChief Financial Officer
34,811
0.0245%
$5.60$194,942+0.45%
2024-03-06SaleChief Commercial Officer
17,777
0.0125%
$5.60$99,551+0.45%
2024-03-06SaleEVP, General Counsel
57,745
0.0407%
$5.60$323,372+0.45%
2024-02-27SaleEVP, Research and Development
4,930
0.0034%
$6.10$30,073-7.48%
2024-02-20SaleChief Commercial Officer
15,867
0.0108%
$5.48$86,951+0.18%
2024-02-20SaleEVP, Research and Development
25,146
0.0171%
$5.48$137,800+0.18%
2023-05-23Saledirector
8,733
0.0061%
$11.26$98,334-27.72%
2023-05-23Saledirector
4,650
0.0032%
$11.26$52,359-27.72%
2023-05-23Saledirector
4,818
0.0034%
$11.26$54,251-27.72%
2023-05-23Saledirector
4,815
0.0034%
$11.26$54,217-27.72%

Insider Historical Profitability

24.55%
Greenleaf PeterChief Executive Officer
1522114
1.0631%
$8.8813+37.58%
Donley Matthew MaxwellEVP, Ops & Strategy
584072
0.4079%
$8.8822+67.17%
Miller Joseph MChief Financial Officer
495928
0.3464%
$8.8813+37.58%
Habig Scott MichaelChief Commercial Officer
456338
0.3187%
$8.8813+81.51%
Robertson Stephen P.EVP, General Counsel
443824
0.31%
$8.8812<0.0001%
Knappertz VolkerEVP, Research and Development
319128
0.2229%
$8.8802
Jayne David R.W.director
44364
0.031%
$8.8802
Billen Danieldirector
28141
0.0197%
$8.8802
MacKay-Dunn R. Hectordirector
18595
0.013%
$8.8832+16.06%
Balakrishnan Brindadirector
17523
0.0122%
$8.8801
Bailey Jeffrey Allendirector
13356
0.0093%
$8.8801
Leversage Jilldirector
12918
0.009%
$8.8832<0.0001%
Smith Karen L.director
12672
0.0089%
$8.8801
Solomons NeilChief Medical Officer
90953
0.0635%
$8.88010
Martin Michael RobertChief Business Officer
89512
0.0625%
$8.88115+80.79%
MILNE GEORGE M JRdirector
70000
0.0489%
$8.8830+0.26%
Huizinga Robert BindertEVP of Research
69379
0.0485%
$8.8806
Colao MassimilanoChief Commercial Officer
13495
0.0094%
$8.8801
Hagan Joseph Pdirector
11961
0.0084%
$8.8802

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Armistice Capital Llc$61.42M8.5712.26M+28.57%+$13.65M0.2
BlackRock$43.4M6.068.66M-2.89%-$1.29M<0.01
Nea Management Company Llc$19.89M2.783.97M0%+$00.09
State Street$13.88M1.942.77M+2.46%+$333,074.83<0.01
Goldman Sachs$10.78M1.512.15M+5.06%+$519,527.00<0.01
Nuveen$10.32M1.442.06M-12.46%-$1.47M<0.01
Tang Capital Management, LLC$10.27M1.432.05M+272.73%+$7.51M0.04
Geode Capital Management$8.03M1.121.6M+2.16%+$170,059.42<0.01
The Vanguard Group$7.67M1.071.53M+1.4%+$105,806.19<0.0001
Morgan Stanley$6.53M0.911.3M-10.36%-$754,946.95<0.0001
ROCK SPRINGS CAPITAL MANAGEMENT, LP$5.76M0.81.15M+178.82%+$3.7M0.15
Schroder Investment Management Group$5.21M0.731.04M0%+$00.01
Northern Trust$5.12M0.721.02M-4.16%-$222,358.79<0.01
Citigroup$3.8M0.53759,269-46.41%-$3.29M<0.01
683 Capital Management Llc$3.08M0.43615,000+179.54%+$1.98M0.33
Charles Schwab$2.7M0.38538,958+23%+$504,842.75<0.01
Woodline Partners LP$2.51M0.35500,555-22.42%-$724,641.520.02
State of Wisconsin Investment Board$2.19M0.31436,882+61.12%+$830,272.300.01
BNY Mellon$2.06M0.29411,211+4.46%+$88,040.77<0.0001
Group One Trading$1.89M0.26377,322-44.42%-$1.51M0.03
Gsa Capital Partners Llp$1.75M0.24349,204+196.08%+$1.16M0.14
Susquehanna International Group$1.69M0.24337,757-67.29%-$3.48M<0.01
Nordea Investment Management Ab$1.55M0.22308,500+51.67%+$528,653.00<0.01
JPMorgan Chase$1.54M0.22307,931+40.54%+$445,028.48<0.0001
Trexquant Investment LP$1.47M0.21294,201New+$1.47M0.03
Hudson Bay Capital Management LP$1.45M0.2290,400+213.95%+$991,479.000.01
Balyasny Asset Management Llc$1.45M0.2288,875-67.43%-$3M<0.01
Swiss National Bank$1.35M0.19268,5000%+$0<0.01
Citadel Advisors LLC$1.34M0.19268,403-53.62%-$1.55M<0.01
Jupiter Fund Management$1.24M0.17247,052+21.29%+$217,263.74<0.01
Renaissance Technologies$1.23M0.17244,600+81.19%+$548,896.16<0.01
Campbell Co Investment Adviser Llc$1.19M0.17237,095+2.02%+$23,466.840.1
Level Four Advisory Services Llc$2.13M0.17236,8000%+$00.09
Credit Suisse$1.1M0.15219,4680%+$0<0.01
UBS$1.01M0.14200,782-20.79%-$264,057.11<0.0001
Sunbelt Securities$928,228.000.13185,275-3.78%-$36,447.760.12
Advisory Services Network Llc$932,311.000.13186,090-1.55%-$14,714.370.02
RhumbLine Advisers$921,285.000.13183,892+1.41%+$12,765.29<0.01
Barclays$865,000.000.12172,724-20.93%-$228,980.31<0.0001
Qube Research & Technologies$862,487.000.12172,153New+$862,487.00<0.01
Ubs Asset Management Americas Inc$802,342.000.11160,1480%+$0<0.0001
Invesco$706,685.000.1141,055-2.51%-$18,206.33<0.0001
CalSTRS$682,803.000.1136,288-5.09%-$36,638.14<0.01
AllianceBernstein$678,855.000.1135,5000%+$0<0.0001
Legal & General$660,113.000.09131,759-0.63%-$4,188.36<0.0001
Bank of America$583,188.000.08116,405+67.7%+$235,424.49<0.0001
Jane Street Capital$550,178.000.08109,816-81.15%-$2.37M<0.01
Simplex Trading Llc$543,000.000.08108,528-46.94%-$480,353.470.02
Alps Advisors Inc$511,050.000.07102,006+1.47%+$7,424.82<0.01
Algert Global LLC$469,000.000.0793,700New+$469,000.000.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.